Evidence map›Paper›PMID 41201423›Full record

ArticleJACC. Asia2026

Burden and Risk Factors of Cardiovascular Diseases in Asia, 1990-2021: An Analysis for GBD 2021.

Yuxin Zhang, Qiuju Deng, Piaopiao Hu, Qinghui Zeng, Bingxiao Li, Jing Liu

Abstract read
In one paragraph

Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxin ZhangCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Qiuju DengCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Piaopiao HuCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Qinghui ZengCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Bingxiao LiCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Jing LiuCenter for Clinical and Epidemiological Research, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. Electronic address: jingliu@ccmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite ongoing prevention efforts, the burden of cardiovascular disease (CVD) continues to rise with rapidly aging population and lifestyle changes. Comprehensive reports on CVD burden for Asia remain limited.

objectivesThe aims of this study were to quantify the CVD burden in Asia from 1990 to 2021 and to investigate associated risk factors and their temporal rank changes.

methodsData from the Global Burden of Disease (GBD) 2021 study were used to estimate the prevalence, disability-adjusted life years (DALYs), and mortality of CVD from 1990 to 2021 across 6 Asian regions, age groups, and sex. Twenty-seven behavioral, environmental, and metabolic risk factors were analyzed.

resultsIn 2021, Asia accounted for 270.4 million DALYs and 11.8 million deaths of CVD, representing 61.3% of global CVD mortality. The age-standardized DALYs rate (ASDR) in Asia exceeded the global average by 8.3%. The ASDR was highest in Central Asia but lowest in the high-income Asia Pacific region among the 6 Asian regions. From 1990 to 2021, ASDR and age-standardized mortality rate declined by 27.5% and 25.4%, respectively, whereas age-standardized prevalence increased by 71.7%. Ischemic heart disease and stroke collectively contributed to more than 80% of CVD deaths. High systolic blood pressure persisted as the leading risk factor, while particulate matter pollution emerged as a leading contributor to CVD burden in Asia.

conclusionsDespite declines in ASDR and age-standardized mortality rate, the absolute CVD burden in Asia has increased sharply. Regional disparities in CVD burden and risk factors profiles highlight the necessity for targeted interventions.

Indexed as

cardiovascular diseaseGlobal Burden of Diseaserisk factor

Identifiers

PMID41201423
PMCPMC13491087

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.